中性粒细胞
支气管肺泡灌洗
弹性蛋白酶
医学
炎症
肺
中性粒细胞弹性蛋白酶
胰弹性蛋白酶
免疫学
细胞因子
病理
化学
内科学
生物化学
酶
作者
Utako Fujii,Nobuaki Miyahara,Akihiko Taniguchi,Koichi Waseda,Daisuke Morichika,Etsuko Kurimoto,光 古賀,Mikio Kataoka,Erwin W. Gelfand,Daniel J. Cua,Akihiko Yoshimura,Mitsune Tanimoto,Arihiko Kanehiro
标识
DOI:10.1165/rcmb.2016-0015oc
摘要
Abstract We recently reported that IL-17A plays a critical role in the development of porcine pancreatic elastase (PPE)–induced emphysema. The proliferation of T-helper type 17 (Th17) cells was induced by IL-23. To determine the contribution of IL-23 to the development of pulmonary emphysema, a mouse model of PPE-induced emphysema was used in which responses of IL-23p19–deficient (IL-23−/−) and wild-type (WT) mice were compared. Intratracheal instillation of PPE induced emphysematous changes in the lungs and was associated with increased levels of IL-23 in lung homogenates. Compared with WT mice, IL-23−/− mice developed significantly lower static compliance values and markedly reduced emphysematous changes on histological analyses after PPE instillation. These changes were associated with lower levels of IL-17A and fewer Th17 cells in the lung. The neutrophilia seen in bronchoalveolar lavage fluid of WT mice was attenuated in IL-23−/− mice, and the reduction was associated with decreased levels of keratinocyte-derived cytokine and macrophage inflammatory protein-2 in bronchoalveolar lavage fluid. Treatment with anti–IL-23p40 monoclonal antibody significantly attenuated PPE-induced emphysematous changes in the lungs of WT mice. These data identify the important contributions of IL-23 to the development of elastase-induced pulmonary inflammation and emphysema, mediated through an IL-23/IL-17 pathway. Targeting IL-23 in emphysema is a potential therapeutic strategy for delaying disease progression.
科研通智能强力驱动
Strongly Powered by AbleSci AI